These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 7511675

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.
    Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW.
    Proc Natl Acad Sci U S A; 1994 Jun 21; 91(13):6245-8. PubMed ID: 7517044
    [Abstract] [Full Text] [Related]

  • 25. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
    Kim YU, Kinoshita T, Molina H, Hourcade D, Seya T, Wagner LM, Holers VM.
    J Exp Med; 1995 Jan 01; 181(1):151-9. PubMed ID: 7528766
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Purification and characterization of decay-accelerating factor (DAF) from Raji cells.
    Fujita T, Shinkai Y, Inoue T, Tamura N.
    Immunology; 1988 Jul 01; 64(3):369-74. PubMed ID: 2457546
    [Abstract] [Full Text] [Related]

  • 28. Decay accelerating factor regulates complement activation on glomerular epithelial cells.
    Quigg RJ, Nicholson-Weller A, Cybulsky AV, Badalamenti J, Salant DJ.
    J Immunol; 1989 Feb 01; 142(3):877-82. PubMed ID: 2464030
    [Abstract] [Full Text] [Related]

  • 29. A monoclonal antibody that blocks the complement regulatory activity of guinea pig erythrocytes and characterization of the antigen involved as guinea pig decay-accelerating factor.
    Okada N, Tanaka H, Takizawa H, Okada H.
    J Immunol; 1995 Jun 01; 154(11):6103-11. PubMed ID: 7538542
    [Abstract] [Full Text] [Related]

  • 30. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
    Simpson KL, Jones A, Norman S, Holmes CH.
    Am J Pathol; 1997 Nov 01; 151(5):1455-67. PubMed ID: 9358772
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.
    Schönermark S, Rauterberg EW, Shin ML, Löke S, Roelcke D, Hänsch GM.
    J Immunol; 1986 Mar 01; 136(5):1772-6. PubMed ID: 2419413
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis.
    Charreau B, Cassard A, Tesson L, Le Mauff B, Blanchard D, Lublin D, Soulillou JP, Anegon I.
    Transplant Proc; 1995 Feb 01; 27(1):336-7. PubMed ID: 7533404
    [No Abstract] [Full Text] [Related]

  • 35. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
    Brodbeck WG, Mold C, Atkinson JP, Medof ME.
    J Immunol; 2000 Oct 01; 165(7):3999-4006. PubMed ID: 11034410
    [Abstract] [Full Text] [Related]

  • 36. Decay-accelerating factor in the periovulatory rat ovary.
    Gieske MC, Na GY, Koo Y, Jo M, Curry TE, Ko C.
    J Endocrinol; 2005 Aug 01; 186(2):303-13. PubMed ID: 16079256
    [Abstract] [Full Text] [Related]

  • 37. The complement system in human reproduction.
    Vanderpuye OA, Labarrere CA, McIntyre JA.
    Am J Reprod Immunol; 1992 Aug 01; 27(3-4):145-55. PubMed ID: 1384536
    [Abstract] [Full Text] [Related]

  • 38. Host-specific evasion of the alternative complement pathway by schistosomes correlates with the presence of a phospholipase C-sensitive surface molecule resembling human decay accelerating factor.
    Pearce EJ, Hall BF, Sher A.
    J Immunol; 1990 Apr 01; 144(7):2751-6. PubMed ID: 1690776
    [Abstract] [Full Text] [Related]

  • 39. Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59.
    Ratnoff WD, Knez JJ, Prince GM, Okada H, Lachmann PJ, Medof ME.
    Clin Exp Immunol; 1992 Mar 01; 87(3):415-21. PubMed ID: 1371955
    [Abstract] [Full Text] [Related]

  • 40. Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor.
    Zaltzman AB, Van den Berg CW, Muzykantov VR, Morgan BP.
    Biochem J; 1995 May 01; 307 ( Pt 3)(Pt 3):651-6. PubMed ID: 7537958
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.